MacroGenics
MGNX
#8677
Rank
โ‚น16.30 B
Marketcap
โ‚น256.57
Share price
-6.51%
Change (1 day)
53.05%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2025 (TTM): -โ‚น4.98

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น4.70. In 2024 the company made an earnings per share (EPS) of -โ‚น100.56 a decrease over its 2023 EPS that were of -โ‚น14.10.

EPS history for MacroGenics from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น4.98-95.05%
2024-โ‚น100.56613.33%
2023-โ‚น14.10-92.31%
2022-โ‚น183.27-42.14%
2021-โ‚น316.7236.44%
2020-โ‚น232.14-21.84%
2019-โ‚น296.99-24.58%
2018-โ‚น393.79675.93%
2017-โ‚น50.75-68.05%
2016-โ‚น158.83168.25%
2015-โ‚น59.21-55%
2014-โ‚น131.583400%
2013-โ‚น3.76-108.68%
2012โ‚น43.3224.49%
2011โ‚น34.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น127.82-2,820.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,163-46,139.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,347-28,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น612.77-13,140.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น686.71-14,713.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น279.13-6,040.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น166.35 3,440.00%๐Ÿ‡บ๐Ÿ‡ธ USA